Bristol-Myers Squibb Co. (BMY) PT Raised to $60 at HSBC
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $55.82 +2.05%
Rating Summary:
11 Buy, 23 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 23
Rating Summary:
11 Buy, 23 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 23
Join SI Premium – FREE
HSBC analyst Rajesh Kumar raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $60.00 (from $53.00) while maintaining a Hold rating.
You May Also Be Interested In
- Natera (NTRA) PT Raised to $270 at BTIG
- Outdoor Holding (POWW) PT Raised to $2.75 at Roth/MKM, reiterates Top Pick
- Corbus Pharmaceuticals (CRBP) PT Lowered to $34 at Mizuho
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
